SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-047499
Filing Date
2021-07-20
Accepted
2021-07-20 20:26:33
Documents
2
Period of Report
2021-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1554
2 POA DOCUMENT poa.txt EX-24.3_999861 3762
  Complete submission text file 0001209191-21-047499.txt   6774
Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Babler Martin (Reporting) CIK: 0001435618 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39527 | Film No.: 211102406

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations